Dynamic Challenges of Active Tuberculosis: Prevalence and Risk Factors of Co-Infection in Clinical and Microbiological Characteristics at King Abdulaziz University Hospital, Jeddah, Saudi Arabia

Jawahir A Mokhtar,1– 3 Dalya M Attallah,2 Asif Ahmad Jiman-Fatani,1,2 Mohammed W Al-Rabia,1 Mona Abdulrahman Alqarni,1 Bandar Hasan Saleh,1,2 Maysaa Mohammed Amboon,4 Tarfa A Altorki,3,4 Khalil K Alkuwaity,3,4 Turki Abujamel,3,4 Reham Kaki,5,6 Taghreed Nassir Albarakati,7 Hussam Daghistani,8,9 Mazen...

Full description

Saved in:
Bibliographic Details
Main Authors: Mokhtar JA, Attallah DM, Jiman-Fatani AA, Al-Rabia MW, Alqarni MA, Saleh BH, Amboon MM, Altorki TA, Alkuwaity KK, Abujamel T, Kaki R, Albarakati TN, Daghistani H, Ismail MA, Alharbi O, Abu ITM, Alfadil A, Ibrahem K, Mufrrih M, Sait AM
Format: Article
Language:English
Published: Dove Medical Press 2025-02-01
Series:International Journal of General Medicine
Subjects:
Online Access:https://www.dovepress.com/dynamic-challenges-of-active-tuberculosis-prevalence-and-risk-factors--peer-reviewed-fulltext-article-IJGM
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1823861391896870912
author Mokhtar JA
Attallah DM
Jiman-Fatani AA
Al-Rabia MW
Alqarni MA
Saleh BH
Amboon MM
Altorki TA
Alkuwaity KK
Abujamel T
Kaki R
Albarakati TN
Daghistani H
Ismail MA
Alharbi O
Abu ITM
Alfadil A
Ibrahem K
Mufrrih M
Sait AM
author_facet Mokhtar JA
Attallah DM
Jiman-Fatani AA
Al-Rabia MW
Alqarni MA
Saleh BH
Amboon MM
Altorki TA
Alkuwaity KK
Abujamel T
Kaki R
Albarakati TN
Daghistani H
Ismail MA
Alharbi O
Abu ITM
Alfadil A
Ibrahem K
Mufrrih M
Sait AM
author_sort Mokhtar JA
collection DOAJ
description Jawahir A Mokhtar,1– 3 Dalya M Attallah,2 Asif Ahmad Jiman-Fatani,1,2 Mohammed W Al-Rabia,1 Mona Abdulrahman Alqarni,1 Bandar Hasan Saleh,1,2 Maysaa Mohammed Amboon,4 Tarfa A Altorki,3,4 Khalil K Alkuwaity,3,4 Turki Abujamel,3,4 Reham Kaki,5,6 Taghreed Nassir Albarakati,7 Hussam Daghistani,8,9 Mazen A Ismail,10 Ohood Alharbi,11 Ibrahim Ismail Mohammed Abu,12 Abdelbagi Alfadil,1,13 Karem Ibrahem,1,2 Mohammed Mufrrih,4,14 Ahmad M Sait4,9 1Department of Clinical Microbiology and Immunology, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia; 2Department of Clinical Microbiology Laboratory, King Abdulaziz University Hospital, Jeddah, 21589, Saudi Arabia; 3Vaccines and Immunotherapy Unit, King Fahd Medical Research Center, King Abdulaziz University, Jeddah, 21589, Saudi Arabia; 4Department of Medical Laboratory Sciences, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah, 21589, Saudi Arabia; 5Department of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia; 6Department of Infectious Disease & Infection Control and Environmental Health, King Abdulaziz University Hospital, Jeddah, Saudi Arabia; 7Microbiology Unite in King Fahd General hospital Jeddah (KFHJ), Jeddah, Saudi Arabia; 8Department of Clinical Biochemistry, Faculty of Medicine, King Abdulaziz University Jeddah, Jeddah, 21589, Saudi Arabia; 9Regenerative Medicine Unit, King Fahd Medical Research Center, King Abdulaziz University, Jeddah, 21589, Saudi Arabia; 10Department of Medical Education, Faculty of Medicine, King Abdulaziz University, Jeddah, 21589, Saudi Arabia; 11Department of Microbiology and Parasitology, Faculty of Medicine, Umm Al-Qura University, Makkah, Saudi Arabia; 12Department of Community Medicine, Faculty of medicine, King Abdulaziz University, Jedda, 21589, Saudi Arabia; 13Centre of Research Excellence for Drug Research and Pharmaceutical Industries, King Abdulaziz University, Jeddah, Saudi Arabia; 14Special Infectious Agents Unit BSL-3, King Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi ArabiaCorrespondence: Karem Ibrahem, Department of Clinical Microbiology and Immunology, Faculty of Medicine, King Abdulaziz University, P.O. Box 80205, Jeddah, 21589, Saudi Arabia, Email [email protected]: Tuberculosis (TB) is a major public health issue in Saudi Arabia, particularly impacting the elderly. Immunocompromising conditions, including comorbidities, malignancies, and the use of immunosuppressive agents, are major risk factors for active TB (ATB).Objective: To analyze clinical factors and estimate mortality in TB and drug-resistant cases.Methods: This retrospective study analyzed medical records of 12,494 patients at KAUH (2019– 2021), identifying 131 confirmed TB cases with comprehensive data on demographics, clinical features, comorbidities, diagnostics, and outcomes. Data were analyzed using SPSS, with chi-square and logistic regression identifying risk factors. Statistical significance was determined at a threshold of p < 0.05. In our study, logistic regression was employed to identify significant predictors of mortality among TB patients. The results were presented using beta coefficients (B) to quantify the relationship between predictors and the outcome, along with the adjusted odds ratio (AOR) to provide an interpretable measure of the strength of these associations.Results: Of the 131 TB patients involved in this paper, a higher incidence of pulmonary TB was observed among men under 30 years old. This group also showed a higher mortality rate due to comorbidities such as renal failure, human immunodeficiency virus (HIV), and autoimmune disease. The risk of mortality was heightened by 69.47% with drug susceptibility. Additionally, 19.85% of the patients had multidrug-resistant TB (MDR-TB), and 10.69% had extensively drug-resistant TB (XDR-TB). Patients undergoing hemodialysis, and those with respiratory comorbidities, cancer, diabetes, and smoking were found to have a higher mortality hazard, indicating these as significant risk factors for TB.Conclusion: This study highlights TB’s prevalence and drug resistance at KAUH, emphasizing high-risk groups, including males and young adults. Effective strategies, targeted interventions, and future research are vital for reducing mortality.This study examines the stability of tuberculosis (TB) disease presentation using dynamic models among patients treated at King Abdulaziz University Hospital (KAUH) in Jeddah, Saudi Arabia.Key findings include:This is the first study to analyze TB disease stability across different demographic groups.Males, elderly individuals, cancer patients, and those with pulmonary disease or other comorbidities were found to have a higher risk of death from TB.The results emphasize the need for healthcare practices to adopt the “equilibrium state” method for hazard assessment. Incorporating this gold-standard approach into treatment plans can help identify high-risk cases and improve control measures to reduce TB-related mortality.This study provides valuable insights for improving TB patient care and treatment outcomes, particularly for vulnerable groups.Keywords: Tuberculosis, Pulmonary, Risk Factor, Prevalence, Drug Resistance
format Article
id doaj-art-071391f1dd5544c0a1fb3320d9dfd59c
institution Kabale University
issn 1178-7074
language English
publishDate 2025-02-01
publisher Dove Medical Press
record_format Article
series International Journal of General Medicine
spelling doaj-art-071391f1dd5544c0a1fb3320d9dfd59c2025-02-09T16:10:20ZengDove Medical PressInternational Journal of General Medicine1178-70742025-02-01Volume 1862764199979Dynamic Challenges of Active Tuberculosis: Prevalence and Risk Factors of Co-Infection in Clinical and Microbiological Characteristics at King Abdulaziz University Hospital, Jeddah, Saudi ArabiaMokhtar JAAttallah DMJiman-Fatani AAAl-Rabia MWAlqarni MASaleh BHAmboon MMAltorki TAAlkuwaity KKAbujamel TKaki RAlbarakati TNDaghistani HIsmail MAAlharbi OAbu ITMAlfadil AIbrahem KMufrrih MSait AMJawahir A Mokhtar,1– 3 Dalya M Attallah,2 Asif Ahmad Jiman-Fatani,1,2 Mohammed W Al-Rabia,1 Mona Abdulrahman Alqarni,1 Bandar Hasan Saleh,1,2 Maysaa Mohammed Amboon,4 Tarfa A Altorki,3,4 Khalil K Alkuwaity,3,4 Turki Abujamel,3,4 Reham Kaki,5,6 Taghreed Nassir Albarakati,7 Hussam Daghistani,8,9 Mazen A Ismail,10 Ohood Alharbi,11 Ibrahim Ismail Mohammed Abu,12 Abdelbagi Alfadil,1,13 Karem Ibrahem,1,2 Mohammed Mufrrih,4,14 Ahmad M Sait4,9 1Department of Clinical Microbiology and Immunology, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia; 2Department of Clinical Microbiology Laboratory, King Abdulaziz University Hospital, Jeddah, 21589, Saudi Arabia; 3Vaccines and Immunotherapy Unit, King Fahd Medical Research Center, King Abdulaziz University, Jeddah, 21589, Saudi Arabia; 4Department of Medical Laboratory Sciences, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah, 21589, Saudi Arabia; 5Department of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia; 6Department of Infectious Disease & Infection Control and Environmental Health, King Abdulaziz University Hospital, Jeddah, Saudi Arabia; 7Microbiology Unite in King Fahd General hospital Jeddah (KFHJ), Jeddah, Saudi Arabia; 8Department of Clinical Biochemistry, Faculty of Medicine, King Abdulaziz University Jeddah, Jeddah, 21589, Saudi Arabia; 9Regenerative Medicine Unit, King Fahd Medical Research Center, King Abdulaziz University, Jeddah, 21589, Saudi Arabia; 10Department of Medical Education, Faculty of Medicine, King Abdulaziz University, Jeddah, 21589, Saudi Arabia; 11Department of Microbiology and Parasitology, Faculty of Medicine, Umm Al-Qura University, Makkah, Saudi Arabia; 12Department of Community Medicine, Faculty of medicine, King Abdulaziz University, Jedda, 21589, Saudi Arabia; 13Centre of Research Excellence for Drug Research and Pharmaceutical Industries, King Abdulaziz University, Jeddah, Saudi Arabia; 14Special Infectious Agents Unit BSL-3, King Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi ArabiaCorrespondence: Karem Ibrahem, Department of Clinical Microbiology and Immunology, Faculty of Medicine, King Abdulaziz University, P.O. Box 80205, Jeddah, 21589, Saudi Arabia, Email [email protected]: Tuberculosis (TB) is a major public health issue in Saudi Arabia, particularly impacting the elderly. Immunocompromising conditions, including comorbidities, malignancies, and the use of immunosuppressive agents, are major risk factors for active TB (ATB).Objective: To analyze clinical factors and estimate mortality in TB and drug-resistant cases.Methods: This retrospective study analyzed medical records of 12,494 patients at KAUH (2019– 2021), identifying 131 confirmed TB cases with comprehensive data on demographics, clinical features, comorbidities, diagnostics, and outcomes. Data were analyzed using SPSS, with chi-square and logistic regression identifying risk factors. Statistical significance was determined at a threshold of p < 0.05. In our study, logistic regression was employed to identify significant predictors of mortality among TB patients. The results were presented using beta coefficients (B) to quantify the relationship between predictors and the outcome, along with the adjusted odds ratio (AOR) to provide an interpretable measure of the strength of these associations.Results: Of the 131 TB patients involved in this paper, a higher incidence of pulmonary TB was observed among men under 30 years old. This group also showed a higher mortality rate due to comorbidities such as renal failure, human immunodeficiency virus (HIV), and autoimmune disease. The risk of mortality was heightened by 69.47% with drug susceptibility. Additionally, 19.85% of the patients had multidrug-resistant TB (MDR-TB), and 10.69% had extensively drug-resistant TB (XDR-TB). Patients undergoing hemodialysis, and those with respiratory comorbidities, cancer, diabetes, and smoking were found to have a higher mortality hazard, indicating these as significant risk factors for TB.Conclusion: This study highlights TB’s prevalence and drug resistance at KAUH, emphasizing high-risk groups, including males and young adults. Effective strategies, targeted interventions, and future research are vital for reducing mortality.This study examines the stability of tuberculosis (TB) disease presentation using dynamic models among patients treated at King Abdulaziz University Hospital (KAUH) in Jeddah, Saudi Arabia.Key findings include:This is the first study to analyze TB disease stability across different demographic groups.Males, elderly individuals, cancer patients, and those with pulmonary disease or other comorbidities were found to have a higher risk of death from TB.The results emphasize the need for healthcare practices to adopt the “equilibrium state” method for hazard assessment. Incorporating this gold-standard approach into treatment plans can help identify high-risk cases and improve control measures to reduce TB-related mortality.This study provides valuable insights for improving TB patient care and treatment outcomes, particularly for vulnerable groups.Keywords: Tuberculosis, Pulmonary, Risk Factor, Prevalence, Drug Resistancehttps://www.dovepress.com/dynamic-challenges-of-active-tuberculosis-prevalence-and-risk-factors--peer-reviewed-fulltext-article-IJGMtuberculosispulmonaryrisk factorprevalenceand drug resistance.
spellingShingle Mokhtar JA
Attallah DM
Jiman-Fatani AA
Al-Rabia MW
Alqarni MA
Saleh BH
Amboon MM
Altorki TA
Alkuwaity KK
Abujamel T
Kaki R
Albarakati TN
Daghistani H
Ismail MA
Alharbi O
Abu ITM
Alfadil A
Ibrahem K
Mufrrih M
Sait AM
Dynamic Challenges of Active Tuberculosis: Prevalence and Risk Factors of Co-Infection in Clinical and Microbiological Characteristics at King Abdulaziz University Hospital, Jeddah, Saudi Arabia
International Journal of General Medicine
tuberculosis
pulmonary
risk factor
prevalence
and drug resistance.
title Dynamic Challenges of Active Tuberculosis: Prevalence and Risk Factors of Co-Infection in Clinical and Microbiological Characteristics at King Abdulaziz University Hospital, Jeddah, Saudi Arabia
title_full Dynamic Challenges of Active Tuberculosis: Prevalence and Risk Factors of Co-Infection in Clinical and Microbiological Characteristics at King Abdulaziz University Hospital, Jeddah, Saudi Arabia
title_fullStr Dynamic Challenges of Active Tuberculosis: Prevalence and Risk Factors of Co-Infection in Clinical and Microbiological Characteristics at King Abdulaziz University Hospital, Jeddah, Saudi Arabia
title_full_unstemmed Dynamic Challenges of Active Tuberculosis: Prevalence and Risk Factors of Co-Infection in Clinical and Microbiological Characteristics at King Abdulaziz University Hospital, Jeddah, Saudi Arabia
title_short Dynamic Challenges of Active Tuberculosis: Prevalence and Risk Factors of Co-Infection in Clinical and Microbiological Characteristics at King Abdulaziz University Hospital, Jeddah, Saudi Arabia
title_sort dynamic challenges of active tuberculosis prevalence and risk factors of co infection in clinical and microbiological characteristics at king abdulaziz university hospital jeddah saudi arabia
topic tuberculosis
pulmonary
risk factor
prevalence
and drug resistance.
url https://www.dovepress.com/dynamic-challenges-of-active-tuberculosis-prevalence-and-risk-factors--peer-reviewed-fulltext-article-IJGM
work_keys_str_mv AT mokhtarja dynamicchallengesofactivetuberculosisprevalenceandriskfactorsofcoinfectioninclinicalandmicrobiologicalcharacteristicsatkingabdulazizuniversityhospitaljeddahsaudiarabia
AT attallahdm dynamicchallengesofactivetuberculosisprevalenceandriskfactorsofcoinfectioninclinicalandmicrobiologicalcharacteristicsatkingabdulazizuniversityhospitaljeddahsaudiarabia
AT jimanfataniaa dynamicchallengesofactivetuberculosisprevalenceandriskfactorsofcoinfectioninclinicalandmicrobiologicalcharacteristicsatkingabdulazizuniversityhospitaljeddahsaudiarabia
AT alrabiamw dynamicchallengesofactivetuberculosisprevalenceandriskfactorsofcoinfectioninclinicalandmicrobiologicalcharacteristicsatkingabdulazizuniversityhospitaljeddahsaudiarabia
AT alqarnima dynamicchallengesofactivetuberculosisprevalenceandriskfactorsofcoinfectioninclinicalandmicrobiologicalcharacteristicsatkingabdulazizuniversityhospitaljeddahsaudiarabia
AT salehbh dynamicchallengesofactivetuberculosisprevalenceandriskfactorsofcoinfectioninclinicalandmicrobiologicalcharacteristicsatkingabdulazizuniversityhospitaljeddahsaudiarabia
AT amboonmm dynamicchallengesofactivetuberculosisprevalenceandriskfactorsofcoinfectioninclinicalandmicrobiologicalcharacteristicsatkingabdulazizuniversityhospitaljeddahsaudiarabia
AT altorkita dynamicchallengesofactivetuberculosisprevalenceandriskfactorsofcoinfectioninclinicalandmicrobiologicalcharacteristicsatkingabdulazizuniversityhospitaljeddahsaudiarabia
AT alkuwaitykk dynamicchallengesofactivetuberculosisprevalenceandriskfactorsofcoinfectioninclinicalandmicrobiologicalcharacteristicsatkingabdulazizuniversityhospitaljeddahsaudiarabia
AT abujamelt dynamicchallengesofactivetuberculosisprevalenceandriskfactorsofcoinfectioninclinicalandmicrobiologicalcharacteristicsatkingabdulazizuniversityhospitaljeddahsaudiarabia
AT kakir dynamicchallengesofactivetuberculosisprevalenceandriskfactorsofcoinfectioninclinicalandmicrobiologicalcharacteristicsatkingabdulazizuniversityhospitaljeddahsaudiarabia
AT albarakatitn dynamicchallengesofactivetuberculosisprevalenceandriskfactorsofcoinfectioninclinicalandmicrobiologicalcharacteristicsatkingabdulazizuniversityhospitaljeddahsaudiarabia
AT daghistanih dynamicchallengesofactivetuberculosisprevalenceandriskfactorsofcoinfectioninclinicalandmicrobiologicalcharacteristicsatkingabdulazizuniversityhospitaljeddahsaudiarabia
AT ismailma dynamicchallengesofactivetuberculosisprevalenceandriskfactorsofcoinfectioninclinicalandmicrobiologicalcharacteristicsatkingabdulazizuniversityhospitaljeddahsaudiarabia
AT alharbio dynamicchallengesofactivetuberculosisprevalenceandriskfactorsofcoinfectioninclinicalandmicrobiologicalcharacteristicsatkingabdulazizuniversityhospitaljeddahsaudiarabia
AT abuitm dynamicchallengesofactivetuberculosisprevalenceandriskfactorsofcoinfectioninclinicalandmicrobiologicalcharacteristicsatkingabdulazizuniversityhospitaljeddahsaudiarabia
AT alfadila dynamicchallengesofactivetuberculosisprevalenceandriskfactorsofcoinfectioninclinicalandmicrobiologicalcharacteristicsatkingabdulazizuniversityhospitaljeddahsaudiarabia
AT ibrahemk dynamicchallengesofactivetuberculosisprevalenceandriskfactorsofcoinfectioninclinicalandmicrobiologicalcharacteristicsatkingabdulazizuniversityhospitaljeddahsaudiarabia
AT mufrrihm dynamicchallengesofactivetuberculosisprevalenceandriskfactorsofcoinfectioninclinicalandmicrobiologicalcharacteristicsatkingabdulazizuniversityhospitaljeddahsaudiarabia
AT saitam dynamicchallengesofactivetuberculosisprevalenceandriskfactorsofcoinfectioninclinicalandmicrobiologicalcharacteristicsatkingabdulazizuniversityhospitaljeddahsaudiarabia